A Phase III Randomized, Multicenter, Two Arms Double-blind Trial Versus Placebo, Evaluating the Interest of a Dietary Supplementation With Docosahexaenoic Acid (DHA) During Chemotherapy for Metastatic Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docosahexaenoic acid (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms DHALYA
- 29 Jul 2015 Biomarkers information updated
- 17 Mar 2012 New trial record